Literature DB >> 19684888

Vitamin D Receptor Genetic Polymorphisms and Prostate Cancer Risk: A Meta-analysis of 36 Published Studies.

Ming Yin1, Sheng Wei, Qingyi Wei.   

Abstract

To update data on the role of vitamin D receptor (VDR) single nucleotide polymorphisms (SNPs) in susceptibility to prostate cancer, we performed a meta-analysis of 36 eligible publications on the association of Taql, Apal, Bsml, Fokl and CDX2 SNPs of the VDR gene with prostate cancer risk. Our study suggested that the Taql t and Bsml B alleles were associated with reduced prostate cancer risk among all study populations. Stratified analysis by ethnicity revealed that the Apal a allele was associated with reduced prostate cancer risk only among Asian populations, whereas the Fokl f allele showed a trend of increased prostate cancer risk only among Caucasian populations in a dominant model, independent of tumor stage (local or advanced). These results suggest that VDR polymorphisms may be potential biomarkers for prostate cancer susceptibility.

Entities:  

Keywords:  Genetic polymorphism; Meta-analysis; Molecular Epidemiology; Prostate cancer

Year:  2009        PMID: 19684888      PMCID: PMC2719705     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  57 in total

1.  Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese.

Authors:  M Watanabe; K Fukutome; M Murata; H Uemura; Y Kubota; J Kawamura; R Yatani
Journal:  Anticancer Res       Date:  1999 Sep-Oct       Impact factor: 2.480

2.  Lack of association of VDR polymorphisms with Thai prostate cancer as compared with benign prostate hyperplasia and controls.

Authors:  Suchart Chaimuangraj; Ratdumrong Thammachoti; Boonsong Ongphiphadhanakul; Witaya Thammavit
Journal:  Asian Pac J Cancer Prev       Date:  2006 Jan-Mar

3.  Identification of VDR-responsive gene signatures in breast cancer cells.

Authors:  Kelly Towsend; Victor Trevino; Francesco Falciani; Paul M Stewart; Martin Hewison; Moray J Campbell
Journal:  Oncology       Date:  2007-03-21       Impact factor: 2.935

4.  Vitamin D receptor polymorphisms as markers in prostate cancer.

Authors:  L Correa-Cerro; P Berthon; J Häussler; S Bochum; E Drelon; P Mangin; G Fournier; T Paiss; O Cussenot; W Vogel
Journal:  Hum Genet       Date:  1999-09       Impact factor: 4.132

5.  Genetic variants in the vitamin D receptor gene and prostate cancer risk.

Authors:  Vanessa M Hayes; Gianluca Severi; Emma J D Padilla; Sarah A Eggleton; Melissa C Southey; Robert L Sutherland; John L Hopper; Graham G Giles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

6.  Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.

Authors:  Mohammed T Tayeb; Caroline Clark; Neva E Haites; Linda Sharp; Graeme I Murray; Howard L McLeod
Journal:  Saudi Med J       Date:  2004-04       Impact factor: 1.484

Review 7.  Diet, lifestyle and risk of prostate cancer.

Authors:  Alicja Wolk
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

8.  Prediction of bone density from vitamin D receptor alleles.

Authors:  N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

9.  Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population.

Authors:  Kazuhiro Suzuki; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Tomoyuki Takei; Hidekazu Koike; Haruki Nakazato; Hironobu Okugi; Masaru Hasumi; Yoshitatsu Fukabori; Kohei Kurokawa; Hidetoshi Yamanaka
Journal:  Int J Urol       Date:  2003-05       Impact factor: 3.369

10.  Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.

Authors:  Ingrid Oakley-Girvan; David Feldman; T Ross Eccleshall; Richard P Gallagher; Anna H Wu; Laurence N Kolonel; Jerry Halpern; Raymond R Balise; Dee W West; Ralph S Paffenbarger; Alice S Whittemore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-08       Impact factor: 4.254

View more
  20 in total

1.  Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis.

Authors:  Edmondo Falleti; Davide Bitetto; Carlo Fabris; Annarosa Cussigh; Elisabetta Fontanini; Ezio Fornasiere; Elisa Fumolo; Sara Bignulin; Sara Cmet; Rosalba Minisini; Mario Pirisi; Pierluigi Toniutto
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

2.  Influence of BsmI polymorphism in vitamin D receptor gene on the risk of fracture in Caucasian populations: a meta analysis.

Authors:  Jiazhi Gao; Lei Wang; Jianhua Zhu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Authors:  Irene M Shui; Alison M Mondul; Sara Lindström; Konstantinos K Tsilidis; Ruth C Travis; Travis Gerke; Demetrius Albanes; Lorelei A Mucci; Edward Giovannucci; Peter Kraft
Journal:  Cancer       Date:  2015-03-02       Impact factor: 6.860

4.  Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D3) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy.

Authors:  David Jarrard; Badrinath Konety; Wei Huang; Tracy Downs; Jill Kolesar; Kyung Mann Kim; Tom Havighurst; Joel Slaton; Margaret G House; Howard L Parnes; Howard H Bailey
Journal:  Am J Clin Exp Urol       Date:  2016-09-20

5.  Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.

Authors:  Whitney K Hendrickson; Richard Flavin; Julie L Kasperzyk; Michelangelo Fiorentino; Fang Fang; Rosina Lis; Christopher Fiore; Kathryn L Penney; Jing Ma; Philip W Kantoff; Meir J Stampfer; Massimo Loda; Lorelei A Mucci; Edward Giovannucci
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

6.  Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study.

Authors:  Glovioell W Rowland; Gary G Schwartz; Esther M John; Sue Ann Ingles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11-05       Impact factor: 4.254

7.  Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.

Authors:  Delores J Grant; Cathrine Hoyo; Lucy Akushevich; Edwin S Iversen; Regina Whitaker; Jeffrey Marks; Andrew Berchuck; Joellen M Schildkraut
Journal:  Gynecol Oncol       Date:  2012-12-21       Impact factor: 5.482

8.  Admixture Mapping Links RACGAP1 Regulation to Prostate Cancer in African Americans.

Authors:  Bradford D Wilson; Luisel J Ricks-Santi; Tshela E Mason; Muneer Abbas; Rick A Kittles; Georgia M Dunston; Yasmine M Kanaan
Journal:  Cancer Genomics Proteomics       Date:  2018 May-Jun       Impact factor: 4.069

9.  Study of Vitamin D Receptor Gene Polymorphism (FokI, TaqI and ApaI) Among Prostate Cancer Patients in North India.

Authors:  Pankaj Ramrao Kambale; Deepa Haldar; B C Kabi; Kalpana Pankaj Kambale
Journal:  J Clin Diagn Res       Date:  2017-06-01

10.  Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis.

Authors:  Yanling Liu; Chenglin Li; Peizhan Chen; Xiaoguang Li; Mian Li; He Guo; Jingquan Li; Ruiai Chu; Hui Wang
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.